A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy

Author:

Klopstock Thomas1,Yu-Wai-Man Patrick234,Dimitriadis Konstantinos1,Rouleau Jacinthe5,Heck Suzette1,Bailie Maura234,Atawan Alaa234,Chattopadhyay Sandip234,Schubert Marion1,Garip Aylin6,Kernt Marcus6,Petraki Diana7,Rummey Christian7,Leinonen Mika8,Metz Günther7,Griffiths Philip G.234,Meier Thomas7,Chinnery Patrick F.234

Affiliation:

1. 1 Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University, Munich, Germany

2. 2 Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne Foundation Hospital, NE1 4LP, NHS Trust, UK

3. 3 Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne Foundation Hospital, NE1 4LP NHS Trust, UK

4. 4 Mitochondrial Research Group, Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK

5. 5 Ophthalmology Department, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec H2L 4M1, Canada

6. 6 Department of Ophthalmology, Ludwig-Maximilians-University, Munich, 80336 Germany

7. 7 Santhera Pharmaceuticals, 4410 Liestal, Switzerland

8. 8 4Pharma, Stockholm, 16440 Kista, Sweden

Publisher

Oxford University Press (OUP)

Subject

Clinical Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3